Lasa Supergenerics Ltd. Corporate Filings & Announcements

Latest corporate announcements and filings from Lasa Supergenerics Ltd. on BSE

Load latest

Lasa Supergenerics Ltd.

28 Jan 2025

17.10

0.06%

Company Update

Lasa Supergenerics Ltd - 540702 - Announcement under Regulation 30 (LODR)-Raising of Funds

BSE India

Pursuant to Reg 29 and Reg 30 of SEBI LODR , we would like to inform you that Board of Directors in their Meeting held today have considered and approve. 1. Issue of 25 lakhs warrants 2. Cinvening Extra -ordinary General Meeting of the Company on 22th February, 2025 3. Consider and approved Notice of Extra-ordinary general Meeting 4.approve appoinment of Scrutinizer for scrutinizing e-voting process. 5.Considering and approve raising of fund by way of rights issue for amount not exceeding 49 crores

pdf

Lasa Supergenerics Ltd.

28 Jan 2025

17.10

0.06%

Board Meeting

Lasa Supergenerics Ltd - 540702 - Board Meeting Outcome for Outcome Of Board Meeting For Issue …

BSE India

Pursuant to Regulation 29 and 30 of SEBI (Listing obligation and disclosure requirements) Regulations, 2015, we would like to inform you that the Board of Directors in their meeting held today which was commenced at 02.00 P.M. and concluded at 03.45 P.M.

pdf

Lasa Supergenerics Ltd.

22 Jan 2025

17.10

0.06%

Board Meeting

Lasa Supergenerics Ltd - 540702 - Board Meeting Intimation for Issue Of Warrants And Right Issue …

BSE India

Lasa Supergenerics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/01/2025 ,inter alia, to consider and approve Pursuant to Regulation 29 of the Securities and Exchange Board of the India (Listing Obligation and Disclosure Requirement) Regulation, 2015 notice is hereby given that Meeting of the Board of Directors of the Company is scheduled to be held on Tuesday, January 28, 2025, inter alia; 1. To consider, approve, finalize the issue of warrants and price of warrants convertible into equity shares / or equity shares to be issued on preferential basis in accordance with the provisions of SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2018 (SEBI ICDR Regulations). 2. To consider, approve, finalize, the proposal of fund raising by way of equity shares through rights issue in accordance with the provisions of SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2018 (SEBI ICDR Regulations) as permitted under applicable law, subject to such regulatory/statutory approvals as may be required. 3. Any other matter with the permission of chair.

pdf

Lasa Supergenerics Ltd.

22 Jan 2025

17.10

0.06%

Company Update

Lasa Supergenerics Ltd - 540702 - Cancellation of Board Meeting

BSE India

The Board Meeting to be held on 24/01/2025 Stands Cancelled.

pdf

Lasa Supergenerics Ltd.

20 Jan 2025

17.10

0.06%

Company Update

Lasa Supergenerics Ltd - 540702 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

BSE India

Please find enclosed herewith a certificate under 74 (5) of SEBI (Depositories and Participants) Regulations 2018, for quarter ended December 31, 2024 received from Bigshare Services Private Limited , Registrar and Share Transfer Agent of the Company

pdf

Lasa Supergenerics Ltd.

20 Jan 2025

17.10

0.06%

Board Meeting

Lasa Supergenerics Ltd - 540702 - Board Meeting Intimation for Issue Of Warrants

BSE India

Lasa Supergenerics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 24/01/2025 ,inter alia, to consider and approve Pursuant to Regulation 29 of the Securities and Exchange Board of the India (Listing Obligation and Disclosure Requirement) Regulation, 2015 notice is hereby given that Meeting of the Board of Directors of the Company is scheduled to be held on Friday, January 24, 2025, inter alia; 1. To consider, approve, finalize the issue of warrants and price of warrants convertible into equity shares / or equity shares to be issued on preferential basis in accordance with the provisions of SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2018 (SEBI ICDR Regulations). 2. To consider and approve draft notice of Extra -ordinary General Meeting. 3. Any other matter with the permission of chair.

pdf

Lasa Supergenerics Ltd.

31 Dec 2024

17.10

0.06%

SAST

Lasa Supergenerics Ltd - 540702 - Closure of Trading Window

BSE India

This is to inform you that as per the company code of conduct for regulation and monitoring and reporting of trading by insiders in terms of (prohibition of insider trading) regulations 2015, as amended, the trading window for dealing in equity shares of the company has been closed for designated employees and their immediate relatives'' w.e.f january 01, 2025 till 48 hours after the declaration of unaudited financials results (both inclusive days) for the quarter ended december 31, 2024

pdf

Lasa Supergenerics Ltd.

04 Dec 2024, 04:54PM

17.10

0.06%

Company Update

Lasa Supergenerics Ltd - 540702 - Corporate Insolvency Resolution Process (CIRP)-Updates - Corporate Insolvency Resolution Process …

BSE India

In continuation of our annoucement dated 13.11.2024 , dismissal of insolvency application as withdraw from Financial Creditor , kindly find attached order for the same as uploaded by NCLT on 04.12.2024

pdf

Lasa Supergenerics Ltd.

04 Dec 2024, 04:22PM

17.10

0.06%

Company Update

Lasa Supergenerics Ltd - 540702 - Intimation Under Regulation 30 Of SEBI (Listing Obligation And Disclosure …

BSE India

In Continuation of our announcements date 13.11.2024, dismissal of the insolvency application as withdraw by Financial Creditor , kindly find attached order for the same upload by NCLT on 04.12.2024

pdf

Lasa Supergenerics Ltd.

14 Nov 2024

17.10

0.06%

Company Update

Lasa Supergenerics Ltd - 540702 - Disclosure Of Related Party Transaction Under Regulation 23(9) Of SEBI …

BSE India

Pursuant to Reg 23 (9) of SEBI (LODR) Regulations, 2015, please find attached herewith disclosure of Related Party transactions for the quarter and half year ended September 30, 2024

pdf

Is Lasa Supergenerics Ltd. worth buying?

50 Votes:

Buy 76.0%

Sell 18.0%

Hold 6.0%